Abstract
Background/Aims
Clostridium difficile infection (CDI) is a common nosocomial infection associated with substantial morbidity, mortality and increased medical care costs. Although most patients initially respond to therapy, with either metronidazole or vancomycin, about 15-20% of patients experience recurrence. The aim of this study was to analyze the risk factors related to recurrent CDI (RCDI). Methods: We retrospectively reviewed data, from patients diagnosed with CDI during admission at a university hospital between January 2000 and December 2006, for comparison with data from RCDI patients. Results: Among a total of 294 CDI patients, 32 (10.8%) had experienced RCDI. Risk factors for RCDI included anemia, congestive heart failure, respiratory infection, time between admission and CDI diagnosis, duration of antibiotic therapy prior to CDI diagnosis, tube feeding, and gastrointestinal endoscopy. Multivariate analysis revealed that tube feeding was associated with recurrence (odds ratio, 3.65; 95% confidence interval, 1.38-9.65; P=0.009). Conclusions: Patients who received tube feeding were at increased risk of RCDI. Targeting these patients for preventive strategies may contribute to a reduction in the incidence of RCDI. (Intest Res 2012;10: 0-182)
Citations
Citations to this article as recorded by
- Risk factors for nosocomial Clostridioides difficile infection-induced diarrhoea in patients receiving enteral feeding: a scoping review
G. Alasbly, S. Alotaishan, Y. Algindan, R. Khattab
Journal of Hospital Infection.2026; 167: 81. CrossRef - Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review
Tessel M. van Rossen, Rogier E. Ooijevaar, Christina M.J.E. Vandenbroucke-Grauls, Olaf M. Dekkers, Ed J. Kuijper, Josbert J. Keller, Joffrey van Prehn
Clinical Microbiology and Infection.2022; 28(3): 321. CrossRef - European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
Joffrey van Prehn, Elena Reigadas, Erik H. Vogelzang, Emilio Bouza, Adriana Hristea, Benoit Guery, Marcela Krutova, Torbjorn Norén, Franz Allerberger, John E. Coia, Abraham Goorhuis, Tessel M. van Rossen, Rogier E. Ooijevaar, Karen Burns, Bente R. Scharvi
Clinical Microbiology and Infection.2021; 27: S1. CrossRef -
Biological characteristics associated with virulence in
Clostridioides difficile
ribotype 002 in Hong Kong
Ka Yi Kong, Thomas N. Y. Kwong, Hung Chan, Kristine Wong, Samuel S. Y. Wong, Anu P. Chaparala, Raphael C. Y. Chan, Lin Zhang, Joseph J. Y. Sung, Jun Yu, Peter M. Hawkey, Margaret Ip, William K. K. Wu, Sunny H. Wong
Emerging Microbes & Infections.2020; 9(1): 631. CrossRef - Clostridium difficile in Asia: Opportunities for One Health Management
Deirdre A. Collins, Thomas V. Riley
Tropical Medicine and Infectious Disease.2018; 4(1): 7. CrossRef - Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
Abhishek Deshpande, Vinay Pasupuleti, Priyaleela Thota, Chaitanya Pant, David D.K. Rolston, Adrian V. Hernandez, Curtis J. Donskey, Thomas G. Fraser
Infection Control & Hospital Epidemiology.2015; 36(4): 452. CrossRef - Risk Factors for Delayed Recurrence ofClostridium difficileInfection
Ji Won Kim
Intestinal Research.2014; 12(4): 266. CrossRef - Long-Term Clinical Outcome ofClostridium difficileInfection in Hospitalized Patients: A Single Center Study
Young Seok Doh, You Sun Kim, Hye Jin Jung, Young Il Park, Jin Won Mo, Hyun Sung, Kyung Jin Lee, Young Ki Seo, Jeong Seop Moon, Seong Woo Hong
Intestinal Research.2014; 12(4): 299. CrossRef - Epidemiology of Clostridium difficile infection in Asia
Deirdre A Collins, Peter M Hawkey, Thomas V Riley
Antimicrobial Resistance and Infection Control.2013; 2(1): 21. CrossRef - Clostridium difficileInfection: What's New?
Geom Seog Seo
Intestinal Research.2013; 11(1): 1. CrossRef
KASID
Cite
